Cytocentrics is gone. The San Antonio-based company has changed its name and is expanding its operational strategy to grab a larger share of bioscience business in the United States and abroad.
The company’s new name is CytoBioscience. It’s new game plan could help raise San Antonio’s profile in the biotech industry nationally and internationally.
James Garvin, CEO of CytoBioscience, which was founded in Germany and relocated its headquarters to San Antonio in 2015, said a confluence of multiple…
Cytocentrics is gone. The San Antonio-based company has changed its name and is expanding its operational strategy to grab a larger share of bioscience business in the United States and abroad.
The company’s new name is CytoBioscience. It’s new game plan could help raise San Antonio’s profile in the biotech industry nationally and internationally.
James Garvin, CEO of CytoBioscience, which was founded in Germany and relocated its headquarters to San Antonio in 2015, said a confluence of multiple…